Thomas Perkmann

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (13)

Lisa Schneider

Medical University of Vienna

AUSTRIA

View details

Christoph J. Binder

Professor of Atherosclerosis Research

Medical University of Vienna

AUSTRIA

View details

Dominik Wiedemann

Medical University of Vienna

AUSTRIA

View details

Stephan Blüml

Medical University of Vienna

AUSTRIA

View details

Davd Niklas Springer

Medical University of Vienna

AUSTRIA

View details

Helmuth Haslacher

AUSTRIA

View details

Markus Zeitlinger

Medical University of Vienna

AUSTRIA

View details

Michael Wolzt

Prof.

Medical University of Vienna

AUSTRIA

View details

Elisabeth Simader

Medical University of Vienna

AUSTRIA

View details

Thomas Gremmel

Associate Professor

AUSTRIA

View details

Daniel Mrak

Medical University of Vienna

AUSTRIA

View details

Michael Bonelli

Medical University of Vienna

AUSTRIA

View details

Franziska Wittmann

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Perkmann

Research Interests

Explore related searches

Contact this professor

Articles (10)

High immunoglobulin-M levels to oxidation-specific epitopes are associated with lower risk of acute myocardial infarction

Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations

Associations between nailfold capillary aberrations and autoantibodies in children and adults with Raynaud’s phenomenon

Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study.

Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study

Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial

Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices

Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up

Serum antibody response to BNT162b2 after natural SARS-CoV-2 infection.

Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis.

Collaborators (13)

Lisa Schneider

Christoph J. Binder

Dominik Wiedemann

Stephan Blüml

Davd Niklas Springer

Helmuth Haslacher

Markus Zeitlinger

Michael Wolzt

Elisabeth Simader

Thomas Gremmel

Daniel Mrak

Michael Bonelli

Franziska Wittmann

Make your next move.